NEETPGAI
FeaturesBlogComparePricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Features
  • Subjects
  • Previous Year Questions
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Contact & support

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Pathology/Acute Leukemias
    Acute Leukemias
    easy
    microscope Pathology

    What is the most common type of acute leukemia in children?

    A. Acute promyelocytic leukemia (APL)
    B. Acute lymphoblastic leukemia (ALL)
    C. Acute myeloid leukemia (AML)
    D. Acute monocytic leukemia (AMonoL)

    Explanation

    Epidemiology of Acute Leukemias in Children

    Key Point
    Acute lymphoblastic leukemia (ALL) accounts for approximately 75–80% of all childhood acute leukemias, making it the most common hematologic malignancy in children.
    Frequency Distribution
    Table
    Leukemia TypePercentage in ChildrenPeak Age
    ALL75–80%2–5 years
    AML15–20%< 2 years, then increases after age 10
    APL5–10% (of AML)Adolescents and young adults
    AMonoL< 5%Rare in children
    High-YieldNEET PG
    The peak incidence of childhood ALL is between 2–5 years of age. This age group represents the "common ALL" subtype, which carries a relatively favorable prognosis compared to infant ALL (< 1 year) or adolescent ALL (> 10 years).
    Immunophenotypic Subtypes of Childhood ALL
    • B-cell ALL (85%): Most common; includes common ALL (cALL, CD10+) and pre-B ALL
    • T-cell ALL (15%): Associated with older children and worse prognosis
    • Burkitt leukemia: Rare; associated with t(8;14) translocation
    Clinical Pearl
    The favorable prognosis in childhood ALL (event-free survival > 85% in modern protocols) contrasts sharply with adult ALL, which has a 5-year survival of only 40–50%. This difference is due to better chemotherapy tolerance in children and the prevalence of favorable cytogenetics (e.g., hyperdiploidy, t(12;21)) in childhood ALL.
    Warning
    Do not confuse ALL with lymphoma. ALL is a bone marrow–based disease with circulating blasts; lymphoma is a nodal/extranodal disease. However, Burkitt lymphoma and Burkitt leukemia represent a spectrum of the same disease (t(8;14)).

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Pathology Questions

    Join our NEET PG community

    Daily MCQs, study tips, and topper strategies on Telegram.

    Join on Telegram →